NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Oncotarget, 2017-07, Vol.8 (30), p.49548-49563Copyright: © 2017 Chretien et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.17747 ;PMID: 28548938
Full text available